Related Experiment Video
Updated: Aug 8, 2025

Detection of Intracellular Gene Expression in Live Cells of Murine, Human and Porcine Origin Using Fluorescence-labeled Nanoparticles
Published on: November 13, 2015
MicroRNAs in POI, DOR and POR
Jiali Luo1,2, Zhaogui Sun3
1NHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Medical School, Fudan University, Shanghai, China.
Purpose:
Premature ovarian insufficiency (POI) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years. However, the etiology of approximately 90% patients remains unknown. Diminished ovarian reserve (DOR) and poor ovarian response (POR) are related to POI in clinic. The main purpose of this review was to evaluate the roles of microRNAs (miRNAs) in the pathogenesis and therapeutic potential for POI, DOR and POR.
Methods:
A literature search was conducted using six databases (PubMed, EMBASE, Web of Science, Cochrane Library, CNKI and Wangfang Data) to obtain relevant studies.
Results:
This review enlightens expression profiles and functional studies of miRNAs in ovarian insufficiency in animal models and humans. Functional studies emphasized the role of miRNAs in steroidogenesis, granulosa cell proliferation/apoptosis, autophagy and follicular development by regulating target genes in specific pathways, such as the PI3K/AKT/mTOR, TGFβ, MAPK and Hippo pathways. Differentially expressed circulating miRNAs provided novel biomarkers for diagnosis and prediction, such as miR-22-3p and miR-21. Moreover, exosomes derived from stem cells restored ovarian function through miRNAs in chemotherapy-induced POI models.
Conclusion:
Differential miRNA expression profiles in patients and animal models uncovered the underlying mechanisms and biomarkers of ovarian insufficiency. Exosomal miRNAs can restore ovarian function against chemotherapy-induced POI, which needs further investigation to develop novel preventive and therapeutic strategies in clinical practice.
Insights
MicroRNAs (miRNAs) play key roles in premature ovarian insufficiency (POI), diminished ovarian reserve (DOR), and poor ovarian response (POR). Exosomal miRNAs show therapeutic potential for restoring ovarian function, offering new diagnostic and treatment strategies.
Area of Science:
- Reproductive Biology
- Molecular Endocrinology
- Genetics
Background:
- Premature ovarian insufficiency (POI) affects ovarian activity before age 40, with unknown etiology in most cases.
- Diminished ovarian reserve (DOR) and poor ovarian response (POR) are clinically related conditions to POI.
- MicroRNAs (miRNAs) are increasingly recognized for their involvement in reproductive health.
Purpose of the Study:
- To review the role of miRNAs in the pathogenesis of POI, DOR, and POR.
- To evaluate the therapeutic potential of miRNAs for these ovarian conditions.
- To explore miRNAs as diagnostic and predictive biomarkers.
Main Methods:
- Comprehensive literature search across six major scientific databases.
- Analysis of expression profiles and functional studies of miRNAs in human and animal models of ovarian insufficiency.
- Review of studies on circulating miRNAs and exosome-mediated miRNA delivery.
Main Results:
- miRNAs regulate key ovarian functions including steroidogenesis, granulosa cell proliferation, apoptosis, and follicular development via specific signaling pathways.
- Differentially expressed circulating miRNAs, such as miR-22-3p and miR-21, show promise as diagnostic biomarkers.
- Stem cell-derived exosomes carrying miRNAs demonstrated restoration of ovarian function in chemotherapy-induced POI models.
Conclusions:
- miRNA expression profiles elucidate mechanisms and identify biomarkers for ovarian insufficiency.
- Exosomal miRNAs offer a promising avenue for restoring ovarian function, particularly in chemotherapy-induced POI.
- Further research is needed to translate these findings into clinical preventive and therapeutic strategies.
Related Concept Videos
piRNA - Piwi-interacting RNAs
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi

